GNW

Genworth Financial Inc

Add to Watchlist

Advanced Chart

8.340

+0.03(0.361%)1D

Overview
Forecast
Valuation
Earnings

Line

Candle

YTD

High

8.430

Open

8.390

VWAP

8.36

Vol

4.51M

Mkt Cap

3.42B

Low

8.320

Amount

37.72M

EV/EBITDA(TTM)

10.13

Total Shares

435.44M

4.12B

EV/OCF(TTM)

18.09

P/S(TTM)

0.50

Genworth Financial, Inc., through its principal insurance subsidiaries, offers mortgage and long-term care insurance products. The Company is the holding company of Enact Holdings, Inc (Enact Holdings). The Company operates through three segments: Enact, Long-Term Care Insurance, and Life and Annuities. Through Enact Holdings and its mortgage insurance subsidiaries, it provides private mortgage insurance products and services in the United States and operates in all 50 states and the District of Columbia. The Enact segment is engaged in the business of writing and assuming residential mortgage guaranty insurance. The Long-Term Care Insurance segment includes long-term care insurance products. The Life and Annuities segment includes traditional and non-traditional life insurance (term, universal and term universal life insurance as well as corporate-owned life insurance and funding agreements), fixed annuities and variable annuities.

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2026Q1

FY2025Q4

FY2025Q3

0.180

+50%

0.060

+50%

0.060

-45.45%

Estimates Revision

Stock Price

Go Up

+15.67%

In Past 3 Month

2 Analyst Rating

7.91% Upside

Wall Street analysts forecast GNW stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for GNW is 9.00 USD with a low forecast of 8.50 USD and a high forecast of 9.50 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

1 Buy

1 Hold

0 Sell

Moderate Buy

7.91% Upside

Current: 8.340

Low

8.50

Averages

9.00

High

9.50

7.91% Upside

Current: 8.340

Low

8.50

Averages

9.00

High

9.50

Keefe Bruyette

Keefe

Market Perform -> Outperform

upgrade

2025-06-18

Reason

Keefe Bruyette

Keefe

Price Target

2025-06-18

upgrade

Market Perform -> Outperform

Reason

Keefe Bruyette upgraded Genworth to Outperform from Market Perform with a price target of $9, up from $8.50. The company could potentially recover $500M, or $1.25 per share, related to a European payment protection business it previously sold to AXA, and a counter lawsuit between AXA and Santander, the analyst tells investors in a research note. The firm says a ruling is expected mid-to-late summer, and proceeds could total as much as 15%-20% of Genworth's market capitalization. In addition, Genworth currently trades at a 22% discount to its implied sum-of-the-parts with no lawsuit recovery, greater than the 15% average discount since mid-2023, notes Keefe.

Keefe Bruyette

Market Perform

maintain

2025-05-13

Reason

Keefe Bruyette

Price Target

2025-05-13

maintain

Market Perform

Reason

Keefe Bruyette raised the firm's price target on Genworth to $8.50 from $8 and keeps a Market Perform rating on the shares. The firm revised several life insurer EPS estimates and price targets following Q1 results.

See All Ratings

Valuation Metrics

The current forward P/E ratio for Genworth Financial Inc (GNW.N) is 24.09, compared to its 5-year average forward P/E of 7.21. For a more detailed relative valuation and DCF analysis to assess Genworth Financial Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

Strongly Overvalued

5Y Average PE

7.21

Current PE

24.09

Overvalued PE

11.85

Undervalued PE

2.57

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

0.00

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

0.00

Undervalued EV/EBITDA

0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A

5Y Average PS

0.12

Current PS

0.00

Overvalued PS

0.26

Undervalued PS

-0.01